BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 18854486)

  • 21. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
    Chiou CC; Hseih KS
    Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptococcus pneumoniae: infection, inflammation and disease.
    Mitchell TJ
    Adv Exp Med Biol; 2006; 582():111-24. PubMed ID: 16802623
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
    Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
    Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.
    Ogunniyi AD; Mahdi LK; Trappetti C; Verhoeven N; Mermans D; Van der Hoek MB; Plumptre CD; Paton JC
    Infect Immun; 2012 Sep; 80(9):3268-78. PubMed ID: 22778095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal vaccines. WHO position paper.
    Wkly Epidemiol Rec; 1999 Jun; 74(23):177-83. PubMed ID: 10437429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural transformation and genome evolution in Streptococcus pneumoniae.
    Straume D; Stamsås GA; Håvarstein LS
    Infect Genet Evol; 2015 Jul; 33():371-80. PubMed ID: 25445643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problematic resistance of pneumococcal antibiotic resistance].
    Marchal V; Melin P; Hayette MP; Christiaens G; De Mol P
    Rev Med Liege; 2003 Nov; 58(11):675-80. PubMed ID: 14748195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal virulence factors: structure and function.
    Jedrzejas MJ
    Microbiol Mol Biol Rev; 2001 Jun; 65(2):187-207 ; first page, table of contents. PubMed ID: 11381099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell mediated priming following pneumococcal colonization.
    Rabquer B; Shriner AK; Smithson SL; Westerink MA
    Vaccine; 2007 Mar; 25(11):2036-42. PubMed ID: 17240006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model.
    Green BA; Zhang Y; Masi AW; Barniak V; Wetherell M; Smith RP; Reddy MS; Zhu D
    Infect Immun; 2005 Feb; 73(2):981-9. PubMed ID: 15664941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
    Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
    Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pneumococcal antibiotic resistance].
    Moreillon P; Wenger A; Caldelari I
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of nonencapsulated Streptococcus pneumoniae among Japanese children with acute otitis media.
    Hotomi M; Nakajima K; Hiraoka M; Nahm MH; Yamanaka N
    J Infect Chemother; 2016 Feb; 22(2):72-7. PubMed ID: 26705748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptococcus pneumoniae: elusive mechanisms of the body's defense systems.
    Bondi T; Canessa C; Lippi F; Iacopelli J; Nieddu F; Azzari C
    J Prev Med Hyg; 2012 Jun; 53(2):89-93. PubMed ID: 23240166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Pneumococcal vaccine.
    Braido F; Bellotti M; De Maria A; Cazzola M; Canonica GW
    Pulm Pharmacol Ther; 2008 Aug; 21(4):608-15. PubMed ID: 18502670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.